Kerry Group plc is an Irish multinational corporation headquartered in Tralee, County Kerry, Ireland. Founded in 1972, it specializes in the development, manufacture, and supply of taste, nutrition, and functional ingredients primarily for the food, beverage, pharmaceutical, and biotechnology industries.
The company operates through its Taste & Nutrition division, offering innovative solutions such as flavors, enzymes, and specialty chemicals including pharma-grade acetates used in API synthesis, buffering, IV fluids, and dialysis. Through the 2021 acquisition of Niacet, Kerry expanded its portfolio in preservatives, emulsifiers, and pharmaceutical acetates like sodium, calcium, potassium, and ammonium variants, produced under cGMP conditions.
Employing around 23,000 people worldwide, Kerry serves customers in over 140 countries with a focus on sustainable nutrition. In 2023, it reported revenue of €8 billion.
Also known as Kerry Group p.l.c. and Kerry Niacet Pharma.
BYPHAR offers three-tier raw materials (Explore/Enhance/Excel) with GMP/regulatory-ready documentation; co-branded suppliers and global supply, supporting development to commercial manufacturing.
